Christopher Haqq
Technik-/Wissenschafts-/F&E-Leiter bei ELICIO THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Christopher Haqq
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 | - |
Karriereverlauf von Christopher Haqq
Ehemalige bekannte Positionen von Christopher Haqq
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 | 01.06.2023 |
SURROZEN, INC. | Direktor/Vorstandsmitglied | 01.11.2020 | 01.04.2021 |
Independent Dir/Board Member | 01.11.2020 | 01.04.2021 | |
ATARA BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2012 | 25.10.2019 |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Technik-/Wissenschafts-/F&E-Leiter | 29.07.2009 | 01.09.2011 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2007 | 13.07.2009 |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Ausbildung von Christopher Haqq
Harvard Medical School | Doctorate Degree |
Stanford University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
AMGEN INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
ELICIO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Consonance-HFW Acquisition Corp.
Consonance-HFW Acquisition Corp. Financial ConglomeratesFinance Consonance-HFW Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisitions, share purchase, reorganization, or similar business combination. The company was founded by Gad Soffer and Kevin Harold Livingston on August 21, 2020 and is headquartered in Princeton, NJ. | Finance |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Christopher Haqq
- Erfahrung